FDG PET/CT pitfalls in gynecologic and genitourinary oncologic imaging

A Lakhani, SR Khan, N Bharwani, V Stewart… - Radiographics, 2017 - pubs.rsna.org
The role of whole-body positron emission tomography (PET)/computed tomography (CT)
with fluorodeoxyglucose (FDG fluorodeoxyglucose) is now established in the assessment of …

Frusemide aids diagnostic interpretation of 68Ga‐PSMA positron emission tomography/CT in men with prostate cancer

N Fennessy, J Lee, J Shin, B Ho, SA Ali… - Journal of Medical …, 2017 - Wiley Online Library
Introduction 68Ga‐PSMA positron emission tomography–computed tomography (PET/CT) is
useful for both staging and assessment of biochemical relapse in men with prostate cancer …

[HTML][HTML] Efficacy of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography in restaging muscle-invasive bladder cancer following radical …

H Öztürk, İ Karapolat - Experimental and Therapeutic …, 2015 - spandidos-publications.com
The aim of the present study was to retrospectively evaluate the contribution and
effectiveness of 18F‑fluorodeoxyglucose‑positron emission tomography/computed …

Could different hydration protocols affect the quality of 18F-FDG PET/CT images?

L Ceriani, S Suriano, T Ruberto… - Journal of Nuclear …, 2011 - Soc Nuclear Med
In a group of oncologic patients undergoing 18F-FDG PET/CT, we compared 4 different
protocols of hydration to investigate their impact on image quality and to choose the best …

PET-CT in recurrent ovarian cancer: impact on treatment planning

MS Lenhard, A Burges, TRC Johnson… - Anticancer …, 2008 - ar.iiarjournals.org
Background: Positron emission tomography-computed tomography (PET-CT) is currently not
established in the management of recurrent ovarian cancer. Here, its value in diagnosis and …

The effect of furosemide dose timing on bladder activity in oncology imaging with 18F-fluorodeoxyglucose PET/CT

S Nijjar, J Patterson, J Ducharme… - Nuclear medicine …, 2010 - journals.lww.com
Objective To compare the effects of two furosemide administration protocols on bladder
activity during 18 F-fluorodeoxyglucose (18 F-FDG) PET/computed tomography (CT) …

[HTML][HTML] Fluorodeoxyglucose uptake in absence of CT abnormality on PET-CT: What is it?

Y Liu - World journal of radiology, 2013 - ncbi.nlm.nih.gov
The purpose of this article is to provide a pictorial review of the findings and interpretative
pitfalls about focal fluorodeoxyglucose (FDG) uptake in the absence of corresponding …

Patient preparation and patient-related challenges with FDG-PET/CT in infectious and inflammatory disease

S Hess, AM Scholtens, LC Gormsen - PET clinics, 2020 - pet.theclinics.com
The relative nonspecificity of 18F-fluorodeoxyglucose (FDG) is a multifaceted challenge;
accurate differentiation between inflammatory and malignant cells may be difficult because …

Elevated 18F-FDG levels in blood and organs after angiotensin II receptor blocker administration: experiment in mice administered telmisartan

Y Zhao, S Zhao, Y Kuge, N Tamaki - Journal of Nuclear Medicine, 2013 - Soc Nuclear Med
Angiotensin II receptor blockers (ARBs) are a common treatment for hypertensive patients
but affect renal function. In this study, the effects of ARB on 18F-FDG distribution and …

Preliminary study of detecting urothelial malignancy with FDG PET in Taiwanese ESRD patients

SS Sun, CH Chang, HJ Ding, CH Kao, HC Wu… - Anticancer …, 2009 - ar.iiarjournals.org
The study aimed to evaluate the possibility of applying 18F-fluorodeoxyglucose positron-
emission tomography (FDG PET) for detecting primary urothelial malignancies in end-stage …